<http://schema.org/url>
<https://www.genengnews.com/>
<http://www.genengnews.com/Registration.aspx?ReturnURL=%2Fgen-news-highlights%2Fregeneron-and-sanofi-aventis-cancer-drug-misses-phase-iii-primary-endpoint-but-meets-secondary-t%2F81244807%2F>